Full Event Guide

Browse the full Event Guide to discover:

4th Rare & Genetic Kidney Disease Drug Development

3 days packed full of high-quality talks from Astra Zeneca, Novartis, Takeda, Maze Therapeutics, Walden Biosciences and many more

4th Rare & Genetic Kidney Disease Drug Development

Brand new search & evaluation and partnerships focussed panel discussion featuring Everest Medicine, Novartis, and Invizius Therapeutics to discuss how global partnerships can advance clinical development through broader patient reach

4th Rare & Genetic Kidney Disease Drug Development

6+ hours of dedicated networking sessions

Brochure Cover 59039

Having trouble downloading the brochure? Let us know here and we’ll email it to you instead

Companies on the Program: